Mirtazapine Tablet, Film Coated
Product Images NDC 51079-088

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Mirtazapine (NDC 51079-088). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Institutional Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

7f2418f8 F476 4079 835d 1b6b57937c7a 01

7f2418f8 F476 4079 835d 1b6b57937c7a 01
FDA Label Image

Mirtazapine Stuctural Formula (Image 01)

Mirtazapine Stuctural Formula (Image 01)
FDA Label Image

Mirtazapine 15 mg Tablets Unit Carton Label (Image 02)

Mirtazapine 15 mg Tablets Unit Carton Label (Image 02)
FDA Label Image

Unit Carton (Image 03)

Unit Carton (Image 03)
FDA Label Image

Mirtazapine 30 mg Tablets Unit Carton Label (Image 04)

Mirtazapine 30 mg Tablets Unit Carton Label (Image 04)
FDA Label Image

Mirtazapine 45 mg Tablets Unit Carton Label (Image 05)

Mirtazapine 45 mg Tablets Unit Carton Label (Image 05)
NDC 51079-088 and NDC 51079-088-2 are codes for Mirtazapine Tablets, USP. The tablets contain 45mg of Mirtazapine, an antidepressant medication that affects chemicals in the brain. The recommended dosage is decided by a doctor, depending on the patient's condition. The text also includes manufacturing information, including a product code and precautions about storage conditions.*
FDA Label Image

Unit Carton (Image 06)

Unit Carton (Image 06)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.